Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N.

Gut. 2012 Nov;61(11):1600-9. Epub 2012 Jan 20.

PMID:
22267590
2.

CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.

Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, Yu CC, Lo JF.

PLoS One. 2011;6(11):e28053. doi: 10.1371/journal.pone.0028053. Epub 2011 Nov 28.

3.

A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation.

Laudadio I, Manfroid I, Achouri Y, Schmidt D, Wilson MD, Cordi S, Thorrez L, Knoops L, Jacquemin P, Schuit F, Pierreux CE, Odom DT, Peers B, Lemaigre FP.

Gastroenterology. 2012 Jan;142(1):119-29. doi: 10.1053/j.gastro.2011.09.001. Epub 2011 Sep 12.

PMID:
21920465
5.

The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.

Castoldi M, Vujic Spasic M, Altamura S, Elmén J, Lindow M, Kiss J, Stolte J, Sparla R, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU.

J Clin Invest. 2011 Apr;121(4):1386-96. doi: 10.1172/JCI44883.

6.

Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation.

Kim N, Kim H, Jung I, Kim Y, Kim D, Han YM.

Hepatol Res. 2011 Feb;41(2):170-83. doi: 10.1111/j.1872-034X.2010.00752.x.

PMID:
21269386
7.

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.

Burchard J, Zhang C, Liu AM, Poon RT, Lee NP, Wong KF, Sham PC, Lam BY, Ferguson MD, Tokiwa G, Smith R, Leeson B, Beard R, Lamb JR, Lim L, Mao M, Dai H, Luk JM.

Mol Syst Biol. 2010 Aug 24;6:402. doi: 10.1038/msb.2010.58.

8.

Mammalian microRNAs predominantly act to decrease target mRNA levels.

Guo H, Ingolia NT, Weissman JS, Bartel DP.

Nature. 2010 Aug 12;466(7308):835-40. doi: 10.1038/nature09267.

9.

Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Sundaram M, Yao Z.

Nutr Metab (Lond). 2010 Apr 27;7:35. doi: 10.1186/1743-7075-7-35.

10.

MicroRNAs and the regulation of fibrosis.

Jiang X, Tsitsiou E, Herrick SE, Lindsay MA.

FEBS J. 2010 May;277(9):2015-21. doi: 10.1111/j.1742-4658.2010.07632.x. Review.

11.

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.

Shindo N, Fujisawa T, Sugimoto K, Nojima K, Oze-Fukai A, Yoshikawa Y, Wang X, Yasuda O, Ikegami H, Rakugi H.

J Hepatol. 2010 Jun;52(6):903-12. doi: 10.1016/j.jhep.2009.12.033. Epub 2010 Mar 24.

PMID:
20392512
12.

EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.

Terris B, Cavard C, Perret C.

J Hepatol. 2010 Feb;52(2):280-1. doi: 10.1016/j.jhep.2009.10.026. Epub 2009 Nov 10.

13.

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, Kauppinen S, Ørum H.

Science. 2010 Jan 8;327(5962):198-201. doi: 10.1126/science.1178178. Epub 2009 Dec 3.

14.
15.

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC.

Hepatology. 2009 Nov;50(5):1464-74. doi: 10.1002/hep.23221.

PMID:
19821482
16.

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties.

Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS.

Oncogene. 2009 Oct 8;28(40):3526-36. doi: 10.1038/onc.2009.211. Epub 2009 Jul 20.

17.

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences.

Nakagawa H, Maeda S, Yoshida H, Tateishi R, Masuzaki R, Ohki T, Hayakawa Y, Kinoshita H, Yamakado M, Kato N, Shiina S, Omata M.

Int J Cancer. 2009 Nov 15;125(10):2264-9. doi: 10.1002/ijc.24720.

18.

Integration of microRNA miR-122 in hepatic circadian gene expression.

Gatfield D, Le Martelot G, Vejnar CE, Gerlach D, Schaad O, Fleury-Olela F, Ruskeepää AL, Oresic M, Esau CC, Zdobnov EM, Schibler U.

Genes Dev. 2009 Jun 1;23(11):1313-26. doi: 10.1101/gad.1781009.

19.

The stem cell marker CD133 (prominin-1) is phosphorylated on cytoplasmic tyrosine-828 and tyrosine-852 by Src and Fyn tyrosine kinases.

Boivin D, Labbé D, Fontaine N, Lamy S, Beaulieu E, Gingras D, Béliveau R.

Biochemistry. 2009 May 12;48(18):3998-4007. doi: 10.1021/bi900159d.

PMID:
19296573
20.

MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.

Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP.

Hepatology. 2009 May;49(5):1571-82. doi: 10.1002/hep.22806.

PMID:
19296470

Supplemental Content

Support Center